NCT00107835View on ClinicalTrials.gov

Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults

PHASE3CompletedINTERVENTIONAL

Enrollment

408

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

Pain

Interventions

DRUG

S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)

S-Caine Peel comprising a 1:1 eutectic mixture of 7% lidocaine, and 7% tetracaine was applied topically. The study drug remained on the treatment area for 20-30 minutes for minor dermal procedures and 60 minutes for major dermal procedures

Trial Locations (5)

10016

Laser and Skin Surgery Center of New York, New York

33144

International Dermatology Research Inc., Miami

37215

Tennessee Clinical Research Center, Nashville

48038

Midwest Cutaneous Research, Clinton Township

75230

Texas Dermatology Research Institute, Dallas

All Listed Sponsors

lead

ZARS Pharma Inc.

INDUSTRY

NCT00107835 - Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults | Biotech Hunter | Biotech Hunter